Basket - Other

Basket - Other
2026-09-15T00:00:00.000+10:00

HLX48-FIH101

HLX48-FIH101
Basket

Phase I: An open-label study to evaluate safety, tolerability, PK, PD and early signs of clinical efficacy of HLX48 (Anti-EGFRxcMET Bis ADC) in advanced or metastatic solid tumors.

Phase I: An open-label study to evaluate safety, tolerability, PK, PD and early signs of clinical efficacy of HLX48 (Anti-EGFRxcMET Bis ADC) in advanced or metastatic solid tumors.

Trial overview

Clinical Area

Medical Oncology

Disease

Basket

Disease site

Basket

Study Phase

I

Trial Identifiers

Registration number: NCT07473726

https://clinicaltrials.gov/study/NCT07473726

Principal Investigator(s)
Medical Oncologist

Prof. Nick Pavlakis

BSc MBBS MMed PhD FRACP

Prof. Nick Pavlakis
Nick
Pavlakis
View Profile
Profile Image - Prof. Nick Pavlakis

··

··

Thank you for submitting.

Thank you for submitting.

We will be in touch within 24 hours

Form submission error

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

 

* Indicates a required field.

 

The flag of Australia has a dark blue field. It features the flag of the United Kingdom — the Union Jack — in the canton, beneath which is a large white seven-pointed star. A representation of the Southern Cross constellation, made up of one small five-pointed and four larger seven-pointed white stars, is situated on the fly side of the field. dropdown icon
search icon
    +61
    dropdown icon
    • ACT
    • NSW
    • NT
    • QLD
    • VIC
    • SA
    • TAS
    • WA

    Please refer to your hospitals process for inpatient referrals...

    Find a centre